Product Information
AZELASTIN-FLUTIC 137-50 MCG SPR is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $2.1868 per GM under NDC 45802006601. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on Feb 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
137; 50 ug/1; ug/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802006601
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
8/19/2026
Active Ingredients
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA208111FDA Approved
2/18/2021
TE Code
AB
On Market Since
3/1/2021
Pharmacological Classes
Price Statistics
The NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has been published 277 times since May 5, 2021, and over the history we have for it it has declined 60.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1868 per GM |
|---|---|
| All-time high | $5.5637 (May 12, 2021) |
| All-time low | $2.1868 (Aug 19, 2026) |
| 52-week high | $3.2032 |
| 52-week low | $2.1868 |
| Median price | $3.2879 |
| Average price | $3.5297 |
| Largest weekly change | +16.0% (Dec 22, 2021) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the azelastine hydrochloride, fluticasone propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AZELASTIN-FLUTIC 137-50 MCG SPR?
The current National Average Drug Acquisition Cost (NADAC) for AZELASTIN-FLUTIC 137-50 MCG SPR, manufactured by Padagis Israel Pharmaceuticals Ltd, is $2.1868 per GM (NDC 45802006601), effective Aug 19, 2026.
How has the price of AZELASTIN-FLUTIC 137-50 MCG SPR changed over time?
Over the history we have for it, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has declined 60.7%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for AZELASTIN-FLUTIC 137-50 MCG SPR?
Since May 5, 2021, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has ranged from a low of $2.1868 (Aug 19, 2026) to a high of $5.5637 (May 12, 2021), with a median of $3.2879 per GM.
Are there cheaper alternatives to AZELASTIN-FLUTIC 137-50 MCG SPR?
No other NADAC-published product currently shares the active ingredient and strength of AZELASTIN-FLUTIC 137-50 MCG SPR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZELASTIN-FLUTIC 137-50 MCG SPR?
AZELASTIN-FLUTIC 137-50 MCG SPR (NDC 45802006601) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.